Evaluation of inhibitory potencies for compounds inhibiting p-glycoprotein but without maximum effects : F₂ valuesWEISS, Johanna; HAEFELI, Walter Emil.Drug metabolism and disposition. 2006, Vol 34, Num 2, pp 203-207, issn 0090-9556, 5 p.Article

Evidence of P-glycoprotein sequence diversity in cyathostominsDROGEMULLER, Michaela; SCHNIEDER, T; VON SAMSON-HIMMELSTIERNA, G et al.The Journal of parasitology. 2004, Vol 90, Num 5, pp 998-1003, issn 0022-3395, 6 p.Article

Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substratesMOADDEL, Ruin; BULLOCK, Peter L; WAINER, Irving W et al.Journal of chromatography. B. 2004, Vol 799, Num 2, pp 255-263, issn 1570-0232, 9 p.Article

Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforinWANG, Er-Jia; BARECKI-ROACH, Mary; JOHNSON, William W et al.Journal of pharmacy and pharmacology. 2004, Vol 56, Num 1, pp 123-128, issn 0022-3573, 6 p.Article

Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein effluxSHAN, Yong-Qiang; GANG REN; JIANG, Jian-Dong et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 3, pp 446-456, issn 0026-0495, 11 p.Article

New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitorsZHOU, Xiao-Fei; LINPING ZHANG; TSENG, Elaine et al.Drug metabolism and disposition. 2005, Vol 33, Num 3, pp 321-328, issn 0090-9556, 8 p.Article

RÉVERSION DE LA « MULTIDRUG RESISTANCE » DES CANCERS: ESPOIRS ET DÉCEPTIONS = REVERSAL OF CANCER MULTIDRUG RESISTANCE: EXPECTATIONS AND DISAPPOINTMENTSROBERT, Jacques.Bulletin de l'Académie vétérinaire de France. 2011, Vol 164, Num 3, pp 271-274, issn 0001-4192, 4 p.Article

Transcellular transport of aconitine across human intestinal Caco-2 cellsCUIPING YANG; ZHENG LI; TIANHONG ZHANG et al.Food and chemical toxicology. 2013, Vol 57, pp 195-200, issn 0278-6915, 6 p.Article

Anthelmintics Are Substrates and Activators of Nematode P GlycoproteinKERBOEUF, Dominique; GUEGNARD, Fabrice.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 5, pp 2224-2232, issn 0066-4804, 9 p.Article

P-glycoprotein function in the elderlyBRENNER, Stefanie S; KLOTZ, Ulrich.European journal of clinical pharmacology. 2004, Vol 60, Num 2, pp 97-102, issn 0031-6970, 6 p.Article

Characterization of a new antibody raised against the NH₂ terminus of P-glycoproteinRAO, Prema S; GOVINDARAJAN, Rajgopal; MALLYA, Kavita B et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5833-5839, issn 1078-0432, 7 p.Article

Identification of P-Glycoprotein Inhibitors in Contaminated Freshwater SedimentsZAJA, Roko; TERZIC, Senka; SENTA, Ivan et al.Environmental science & technology. 2013, Vol 47, Num 9, pp 4813-4821, issn 0013-936X, 9 p.Article

High Levels of P-Glycoprotein Activity in Human Lymphocytes in the First 6 Months of LifeGIRAUD, C; DECLEVES, X; SCHERRMANN, J. M et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 3, pp 289-295, issn 0009-9236, 7 p.Article

Genetic aspects of multidrug resistancePAULY, M; RIES, F; DICATO, M et al.Medical oncology and tumor pharmacotherapy. 1992, Vol 9, Num 1, pp 21-24, issn 0736-0118Article

Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytesCHAUDHARY, P. M; MECHETNER, E. B; RONINSON, I. B et al.Blood. 1992, Vol 80, Num 11, pp 2735-2739, issn 0006-4971Article

Thalidomide does not interact with P-glycoproteinZIMMERMANN, Christian; GUTMANN, Heike; DREWE, Juergen et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 599-606, issn 0344-5704, 8 p.Article

La glycoprotéine P : un transporteur de médicaments à ne pas négliger : Thérapeutique = The P-glycoprotein: an important transporter for drug dispositionJERDI, M. Clement; DESMEULES, J; DAYER, P et al.Médecine et hygiène. 2004, Vol 62, Num 2476, pp 704-709, issn 0025-6749, 6 p.Article

Multidrug resistance: P-glycoprotein and its allies. The elusive foesCHABNER, B. A; FOJO, A.Journal of the National Cancer Institute. 1989, Vol 81, Num 12, pp 910-913, issn 0027-8874Article

Réversion de la MultiDrug Resistance par inhibition de la glycoprotéine P = MultiDrug Resistance reversal through P-glycoprotein inhibitionROBERT, J.La Lettre du pharmacologue (Boulogne). 2011, Vol 25, Num 4, pp 157-161, issn 0984-452X, 5 p.Article

Quel rôle pour la glycoprotéine-P dans l'activité analgésique des opioïdes? = Function of P-glycoprotein in analgesic activity of opiatesJERDI, M. C; DESMEULES, J; DAYER, P et al.Douleur et analgésie. 2004, Vol 17, Num 2, pp 81-84, issn 1011-288X, 4 p.Article

Multichimiorésistance du mélanome uvéal = Multidrug résistance in uveal melanomaGAMBRELLE, J; LABIALLE, S; DAYAN, G et al.Journal français d'ophtalmologie. 2005, Vol 28, Num 6, pp 652-659, issn 0181-5512, 8 p.Article

Potential P-Glycoprotein-Mediated Drug-Drug Interactions of Antimalarial Agents in Caco-2 cellsOGA, Enoche F; SEKINE, Shuichi; SHITARA, Yoshihisa et al.The American journal of tropical medicine and hygiene. 2012, Vol 87, Num 1, pp 64-69, issn 0002-9637, 6 p.Article

Macelignan: A New Modulator of P-Glycoprotein in Multidrug-Resistant Cancer CellsYOUNG BIN IM; HA, Iiho; KEON WOOK KANG et al.Nutrition and cancer. 2009, Vol 61, Num 4, pp 538-543, issn 0163-5581, 6 p.Article

Functional role of P-glycoprotein in the human blood-placental barrierMÖLSÄ, Melissa; HEIKKINEN, Tuija; HAKKOLA, Jukka et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 2, pp 123-131, issn 0009-9236, 9 p.Article

Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetateCHENG WANG; ZHANG, Jin-Xia; SHEN, Xiao-Ling et al.Biochemical pharmacology. 2004, Vol 68, Num 5, pp 843-855, issn 0006-2952, 13 p.Article